• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Stephen C. Blacklow, MD, PhD

Gustavus Adolphus Pfeiffer Professor of Biological Chemistry and Molecular Pharmacology, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School

Chair, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School

Professor, Cancer Biology, Dana-Farber Cancer Institute

Professor, Pathology, Brigham And Women's Hospital

Contact Info

Stephen Blacklow
Brigham And Women's Hospital
77 Avenue Louis Pasteur
Boston, MA, 02115
Mailstop: room 652D
Phone: 617-525-4415
Fax: 617-525-4414
stephen_blacklow@hms.harvard.edu

Assistant

Not Available.

DF/HCC Program Affiliation

Leukemia
Cancer Cell Biology

Lab Website

Blacklow Lab

Research Abstract

STRUCTURE AND FUNCTION OF TRANSMEMBRANE RECEPTORS



Keywords: lipoprotein receptor, protein structure, Notch, Notch1, nuclear magnetic resonance, protein dynamics.




The long-term goal of our research program is to elucidate the detailed molecular basis for specificity in protein-protein and receptor-ligand interactions, focusing on proteins implicated in human disease. Over the next several years, the laboratory will continue to explore structure-function relationships in proteins of the vascular and hematopoetic systems, with particular emphasis on lipoprotein and Notch receptors.




Lipoprotein receptors. The LDL receptor (LDLR) is the primary mechanism for uptake of cholesterol-carrying lipoprotein particles into cells, and serves as a prototype for a large family of cell surface receptors implicated in biological processes ranging from lipoprotein uptake to Wnt signal transduction. The basis for ligand recognition by the LDLR and related receptors remains poorly understood. We intend to elucidate at a detailed biochemical level how lipoprotein receptors bind to and release their ligands, and understand how other related receptors of this family transmit biological signals.




Mechanism of signal transduction by the human Notch1 receptor. Human Notch1 is a modular, single-pass transmembrane receptor that normally controls cellular differentiation in hematopoetic (and other) cells. The current working model for signaling by Notch receptors is that ligand binding triggers a cascade of proteolytic cleavages that release the intracellular portion of Notch from the membrane, allowing it to migrate to the nucleus where it activates transcription of Notch-responsive genes. The overarching goal of our studies is to elucidate the molecular logic of Notch signaling in different developmental, physiologic, and pathophysiologic contexts. To achieve this goal, we are combining biochemical, molecular, and structural approaches to gain insight into the mechanism of activation of Notch signaling. Our studies focus on three key steps in activation of Notch signals: how does the receptor recognize ligands, how is metalloprotease cleavage prevented prior to ligand binding, and how do the nuclear complexes assemble to activate transcription of target genes?

Publications

View All Publications